Anbio Biotechnology (NASDAQ:NNNN) Shares Up 5.5% – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s share price shot up 5.5% on Thursday. The company traded as high as $3.86 and last traded at $3.9250. 6,260 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 78,430 shares. The stock had previously closed at $3.72.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, October 8th. One equities research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock presently has an average rating of “Hold”.

Anbio Biotechnology Price Performance

The business has a fifty day simple moving average of $5.87 and a 200-day simple moving average of $14.88.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.